Australian Proteome Analysis Facility (Apaf) has purchased Progenesis Discovery v2005 as a component in its rapidly developing integrated proteomics workflow
Nonlinear Dynamics reports that the Australian Proteome Analysis Facility (Apaf) has purchased two full licences of its flagship product, Progenesis Discovery v2005.
Mark Baker, CEO of Apaf, said: "The purchase of Progenesis Discovery provides an important component in our rapidly developing integrated proteomics workflow.
"A valuable asset to both our expanding proteomic contract services and in-house technical R and D programs, Progenesis Discovery is expected to deliver consistent data quality and reproducibility".
Mark Bennett, general manager of Nonlinear Dynamics's US and Pacific Rim operations, said: "As a leading research facility, Apaf has a well-respected understanding of the analysis solutions available in this area.
"We are therefore delighted it has chosen to use Progenesis Discovery as the primary image analysis solution for its growing 2D research portfolio."
